Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
life sciences
national blog main
startups
2
×
adeno-associated virus
akero therapeutics
alexandria venture investments
altitude life science ventures
american society of gene and cell therapy
apellis pharmaceuticals
aragon pharmaceuticals
arch venture partners
boston
boston top stories
boxer capital
corey goodman
deals
dravet syndrome
ed kaye
encoded therapeutics
financing
funding
gene therapy
generation bio
harmony biosciences
hemophilia
illumina
illumina ventures
investment
m&a
matrix capital management
menlo ventures
national top stories
new york blog main
new york top stories
pfizer
precision biosciences
regulatory elements
rna
What
limited
2
×
medicine
approach
bags
biotechs
capital
crude
cutting
despite
edge
effects
encoded
gene
help
illumina’s
investing
investors
lasting
led
limits
long
making
mitigated
nabs
new
partners
progress
promising
push
recession
remains
risk
single
therapy
therapy’s
treatment
venbio
venture
worried
Language
unset
Current search:
limited
×
startups
×
@xconomy.com
4 years ago
VenBio Partners Bags $394M to Back More Medicine-Making Biotechs
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
